VIRAMED BIOTECH AG has a total of 12 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2002. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets biotechnology, measurement and environmental technology are IMMUNOVIA AB, BEIJING JIUQIANG BIOTECHNOLOGY CO LTD and NUCLEA BIOTECHNOLOGIES INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 4 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | Australia | 2 | |
#4 | United States | 2 | |
#5 | Germany | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Measurement | |
#3 | Environmental technology | |
#4 | Audio-visual technology | |
#5 | Chemical engineering |
# | Name | Total Patents |
---|---|---|
#1 | Kronsteiner Lilly | 11 |
#2 | Kintrup Martin | 11 |
#3 | Helbl Vera | 8 |
#4 | Furtmayr Ludwig | 8 |
#5 | Engel Heinz | 7 |
#6 | Thuering-Nahler Heike | 5 |
#7 | Scheide Dierk | 3 |
#8 | Thuring-Nahler Heike | 2 |
#9 | Helbl Vera Dr | 1 |
#10 | Kronsteiner Lilly Dr | 1 |
Publication | Filing date | Title |
---|---|---|
EP3490237A1 | Device and method for parallel evaluation of multiple test areas | |
EP3229024A1 | Zika virus diagnosis | |
US2006281139A1 | Carrier and method for the detection of anti-borrelia antibodies and test kit for use in the diagnosis of Lyme borreliosis infections | |
EP1726960A1 | Carriers and methods for the detection of anti-Borrelia-antibodies and kit for the use in the diagnosis of Lyme-Borrelia infections | |
EP1556697A1 | Means and methods for diagnosing a treponema infection | |
DE10250368A1 | Means and methods for diagnosing treponema infection |